Advanced search
Publication Cover
Expert Review of Vaccines Volume 10, 2011 - Issue 2
Submit an article Journal homepage
153
Views
22
CrossRef citations to date
0
Altmetric
Review

Comparison of different HER2/neu vaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccines

Linda C Benavides Department of Surgery, General Surgery Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Ft. Sam, Houston, TX 78234, USA; Department of Surgery, General Surgery Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Ft. Sam, Houston, TX 78234, USA
,
Alan K Sears Department of Surgery, General Surgery Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Ft. Sam, Houston, TX 78234, USA; Department of Surgery, General Surgery Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Ft. Sam, Houston, TX 78234, USA
,
Jeremy D Gates Department of Surgery, General Surgery Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Ft. Sam, Houston, TX 78234, USA; Department of Surgery, General Surgery Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Ft. Sam, Houston, TX 78234, USA
,
Guy T Clifton Department of Surgery, General Surgery Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Ft. Sam, Houston, TX 78234, USA; Department of Surgery, General Surgery Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Ft. Sam, Houston, TX 78234, USA
,
Kevin S Clive Department of Surgery, General Surgery Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Ft. Sam, Houston, TX 78234, USA; Department of Surgery, General Surgery Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Ft. Sam, Houston, TX 78234, USA
,
Mark G Carmichael Cancer Vaccine Development Program, United States Military Cancer Institute, Department of Surgery, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA; Cancer Vaccine Development Program, United States Military Cancer Institute, Department of Surgery, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA
,
Jarrod P Holmes Department of Hematology and Medical Oncology, Naval Medical Center San Diego, 34800 Bob Wilson Drive, Suite 202, San Diego, CA 92134, USA; Department of Hematology and Medical Oncology, Naval Medical Center San Diego, 34800 Bob Wilson Drive, Suite 202, San Diego, CA 92134, USA
,
Elizabeth A Mittendorf Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1155 Holcombe Boulevard, Houston, TX 77230, USA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1155 Holcombe Boulevard, Houston, TX 77230, USA
,
Sathibalan Ponniah Cancer Vaccine Development Program, United States Military Cancer Institute, Department of Surgery, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA; Cancer Vaccine Development Program, United States Military Cancer Institute, Department of Surgery, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA
&
George E Peoples Department of Surgery, General Surgery Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Ft. Sam, Houston, TX 78234, USA;[email protected]; [email protected]
 show all
Pages 201-210 | Published online: 09 Jan 2014

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Patrick M. McCarthy, G. Travis Clifton, Timothy J. Vreeland, Alexandra M. Adams, Anne E. O’Shea & George E. Peoples. (2021) AE37: a HER2-targeted vaccine for the prevention of breast cancer recurrence. Expert Opinion on Investigational Drugs 30:1, pages 5-11.
Read now
Elham Mohit, Atieh Hashemi & Mojgan Allahyari. (2014) Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines. Expert Review of Clinical Immunology 10:7, pages 927-961.
Read now
Adrian Bot, Francesco Marincola & Kent A Smith. (2013) Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions. Expert Review of Vaccines 12:10, pages 1219-1234.
Read now
Alan K Sears, Sonia A Perez, Guy T Clifton, Linda C Benavides, Jeremy D Gates, Kevin S Clive, Jarrod P Holmes, Nathan M Shumway, David C Van Echo, Mark G Carmichael, Sathibalan Ponniah, Constantin N Baxevanis, Elizabeth A Mittendorf, Michael Papamichail & George E Peoples. (2011) AE37: a novel T-cell-eliciting vaccine for breast cancer. Expert Opinion on Biological Therapy 11:11, pages 1543-1550.
Read now

Articles from other publishers (18)

Alakesh Das, Suman Adhikari, Dikshita Deka, Atil Bisgin, Sujay Paul, Nabajyoti Balidya, Ibrahim Boga, Antara Banerjee & Surajit Pathak. (2023) An Updated Review on Recent Advances in the Usage of Novel Therapeutic Peptides for Breast Cancer Treatment. International Journal of Peptide Research and Therapeutics 29:2.
Crossref
H. M. Treshalina, M. A. Baryshnikova, E. V. Neborak & V. S. Kosorukov. (2022) Peptide antitumor vaccines targeting HER2/neu. Russian Journal of Biotherapy 21:4, pages 22-29.
Crossref
Sagun Parakh, Hui K. Gan, Adam C. Parslow, Ingrid J.G. Burvenich, Antony W. Burgess & Andrew M. Scott. (2017) Evolution of anti-HER2 therapies for cancer treatment. Cancer Treatment Reviews 59, pages 1-21.
Crossref
G. Travis Clifton, Jennifer K. Litton, Karen Arrington, Sathibalan Ponniah, Nuhad K. Ibrahim, Victor Gall, Gheath Alatrash, George E. Peoples & Elizabeth A. Mittendorf. (2017) Results of a Phase Ib Trial of Combination Immunotherapy with a CD8+ T Cell Eliciting Vaccine and Trastuzumab in Breast Cancer Patients. Annals of Surgical Oncology 24:8, pages 2161-2167.
Crossref
Xiaoyu Li & Xia Bu. 2017. Translational Research in Breast Cancer. Translational Research in Breast Cancer 315 330 .
Guy T. Clifton, Holbrook E. Kohrt & George E. Peoples. (2015) Critical issues in cancer vaccine trial design. Vaccine 33:51, pages 7386-7392.
Crossref
Michiko Harao, Elizabeth A. Mittendorf & Laszlo G. Radvanyi. (2014) Peptide-Based Vaccination and Induction of CD8+ T-Cell Responses Against Tumor Antigens in Breast Cancer. BioDrugs 29:1, pages 15-30.
Crossref
Maxwell Omabe, Shahid Ahmed, Amer Sami, Yufeng Xie, Min Tao & Jim Xiang. (2015) HER2-Specific Vaccines for HER2-Positive Breast Cancer Immunotherapy. World Journal of Vaccines 05:02, pages 106-128.
Crossref
Carmen Avendaño & J. Carlos Menéndez. 2015. Medicinal Chemistry of Anticancer Drugs. Medicinal Chemistry of Anticancer Drugs 561 593 .
Martin J. D’Souza, Rikhav P. Gala, Ruhi V. Ubale, Bernadette D’Souza, Trinh Phuong Vo, Ashwin C. Parenky, Nihal S. Mulla, Sucheta D’Sa, Marissa D’Souza, Kim Braz-Gomes, Nigel D’Souza, Maurizio Chiriva-Internati & Susu Zughaier. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies 89 122 .
Edward L Nelson. (2014) HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations. Clinical Investigation 4:9, pages 791-823.
Crossref
S. Chandra, A.C. Pavlick & H.L. Kaufman. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Eric Tartour & Laurence Zitvogel. (2013) Lung cancer: potential targets for immunotherapy. The Lancet Respiratory Medicine 1:7, pages 551-563.
Crossref
J P Pandey, A M Namboodiri, E Kistner-Griffin, M Iwasaki, Y Kasuga, G S Hamada & S Tsugane. (2013) Racially restricted contribution of immunoglobulin Fcγ and Fcγ receptor genotypes to humoral immunity to human epidermal growth factor receptor 2 in breast cancer. Clinical and Experimental Immunology 171:3, pages 273-277.
Crossref
Ursula Wiedermann, Adam B. Davis & Christoph C. Zielinski. (2013) Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines. Breast Cancer Research and Treatment 138:1, pages 1-12.
Crossref
Andrea M. Henle, Courtney L. Erskine, Linda M. Benson, Raphael Clynes & Keith L. Knutson. (2013) Enzymatic Discovery of a HER-2/neu Epitope That Generates Cross-Reactive T Cells. The Journal of Immunology 190:1, pages 479-488.
Crossref
Asad Umar, Barbara K. Dunn & Peter Greenwald. (2012) Future directions in cancer prevention. Nature Reviews Cancer 12:12, pages 835-848.
Crossref
Jooeun Bae, Yu‐Tzu Tai, Kenneth C. Anderson & Nikhil C. Munshi. (2011) Novel epitope evoking CD138 antigen‐specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders. British Journal of Haematology 155:3, pages 349-361.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.